Abstract
Increased small bowel nitric oxide synthase (NOS) activity has been suspected as a cause of postnatal intestinal dysmotility in gastroschisis. The effect of continuous delivery of methylene blue loaded polymer (MBLP) hydroxy-propyl methyl cellulose-ethyl cellulose (HPEC—MC) and daily injection of methylene blue (MB) on the intestinal damage (ID) was evaluated using a chick embryo gastroschisis model. Fourteen-day-old fertilized chick eggs were divided into five groups. In the control (C) group, no intervention was performed. In the sham (S) group, the allantoic and amniotic membranes were opened to create a common cavity that resembles the amniotic cavity in human. In the gastroschisis only (GO) group, a defect in the abdominal wall of the embryo was made, and intestinal loops were exteriorized following connection of amniotic and allantoic cavities. In the gastroschisis plus methylene blue (G+MB) group, gastroschisis was created and MB administered into the amnioallantoic cavity (AAC) by daily injections for 5 days. In the gastroschisis plus methylene blue loaded polymer (G+MBLP) group, MBLP was placed into AAC after gastroschisis was created. At the end of the 19th day of incubation, intestinal morphological changes were investigated macroscopically and microscopically. Although the survival rates were decreased in the chick embryos with creation of gastroschisis compared with C and S groups (p<0.001), the survival rates were increased in G+MBLP group (76.92%) when compared with the GO group (41%) (p<0.001). Because of multiple intervention of embryos, higher mortality was observed in the G-MB group (75.61%). Macroscopic and microscopic scores of ID and mean intestinal wall thickness were significantly higher in the GO group when compared with C, S, G+MB, and G+MBLP groups (p<0.001). The mean score of intestinal ganglia morphology was significantly increased and the total number of ganglion cells was significantly decreased in the GO group when compared with C, S, G+MB, and G+MBLP groups (p<0.001). It is possible to decrease intrauterine intestinal morphological changes in gastroschisis by inhibiting NOS. As a first preliminary study, we believe that use of MBLP may be an alternative for fetal treatment by eliminating the harmful effects of multiple interventions or amniotic fluid exchanges.
Similar content being viewed by others
References
Tibboel D, Raine P, McNee M, et al. (1986) Developmental aspects of gastroschisis. J Pediatr Surg 21:865–869
Klück P, Tibboel D, Van der Kamp AW et al (1983) The effect of fetal urine on the development of the bowel in gastroschisis. J Pediatr Surg 18:47–50
Langer JC, Longaker MT, Crombleholme TM, et al. (1989) Etiology of ID in gastroschisis, l: effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 24:992–997
Langer JC, Bell JG, Castillo RO et al (1990) Etiology of ID in gastroschisis, II: timing and reversibility of histological changes, mucosal function, and contractility. J Pediatr Surg 25:1122–1126
Kanmaz T, Yağmurlu A, Aktuğ T, et al. (2001) The effect of amnio-allantoic fluid pH on the intestines: an experimental study in the chick embryo gastroschisis model. J Pediatr Surg 36:1341–1345
Aktug T, Uçan B, Olguner M et al (1998) Amnio-allantoic fluid exchange for the prevention of intestinal damage in gastroschisis III: determination of waste products removed by exchange. Eur J Pediatr Surg 8:326–328
Aktug T, Erdag G, Kargı A, et al. (1995) Amnio-allantoic fluid exchange for the prevention of intestinal damage in gastroschisis: an experimental study on chick embryos. J Pediatr Surg 30:384–387
Akgür FM, Özdemir T, Olguner M et al (1998) An experimental study investigating the effects of intraperitoneal human neonatal urine and meconium on rat intestines. Res Exp Med 198:207–213
Olguner M, Akgür FM, Api A, et al. (2000) The effects of intraamniotic human neonatal urine and meconium on intestines of chick embryo with gastroschisis. J Pediatr Surg 35:458–461
Bealer JF, Graf J, Bruch SW, et al. (1996) Gastroschisis increases small bowel nitric oxidase synthase activity. J Pediatr Surg 31:1043–1046
Dilsiz A, Gundogan AH, Aktan M, et al. (1999) Nitric oxide synthase inhibition prevents intestinal damage in gastroschisis: a morphological evaluation in chick embryos J Pediatr Surg 34:1248–1252
Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367–374
Mayer B, Brunner F, Schmidt K (1993) Novel actions of methylene blue. Eur Heart J 14:22–26
Volke V, Wegener G, Vasar E, et al. (1996) Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Res 826:303–305
Hutcheson JR, Whittle BJR, Boughto-Smith NK (1990) Role of nitric oxide in maintaining vascular integrity in endotoxine induced acute intestinal damage in the rat. Br J Pharmacol 101:815–820
Tepperman BL, Brown JF, Whittle BJR (1993) Nitric oxide synthase induction and intestinal cell viability in rats. Am J Physiol 264:G214–G218
Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, et al. (1993) Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Denli, Ö., Barlas, M., Bingol-Kologlu, M. et al. The effect on the intestines of continuous release of methylene blue from a drug delivery system: an experimental study in a chick embryo gastroschisis model. Ped Surgery Int 20, 609–613 (2004). https://doi.org/10.1007/s00383-004-1241-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-004-1241-4